What was the mean half-life of Rixubis (nonacog gamma) in the initial pharmacokinetic study in previously treated males aged 15 years and older?

The mean half-life of Rixubis (nonacog gamma) in the initial crossover pharmacokinetic study of 25 evaluable previously treated, non-bleeding males aged 15 years and older was 26.70 hours (SD 9.55 hours).